statistiche ricercatore

Continente	#
NA - Nord America	1.371
AS - Asia	419
EU - Europa	393
SA - Sud America	56
AF - Africa	4
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.244

Nazione	#
US - Stati Uniti d'America	1.363
SG - Singapore	176
CN - Cina	144
GB - Regno Unito	143
SE - Svezia	53
DE - Germania	48
HK - Hong Kong	34
IT - Italia	34
BR - Brasile	31
VN - Vietnam	25
UA - Ucraina	24
FR - Francia	22
RU - Federazione Russa	22
CL - Cile	17
KR - Corea	14
NL - Olanda	10
TR - Turchia	10
BG - Bulgaria	9
FI - Finlandia	9
BE - Belgio	8
ID - Indonesia	5
AR - Argentina	3
CA - Canada	3
IN - India	3
ZA - Sudafrica	3
BD - Bangladesh	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
ES - Italia	2
MX - Messico	2
PL - Polonia	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AZ - Azerbaigian	1
BO - Bolivia	1
CO - Colombia	1
EG - Egitto	1
HN - Honduras	1
HR - Croazia	1
IE - Irlanda	1
JM - Giamaica	1
JP - Giappone	1
LB - Libano	1
LC - Santa Lucia	1
PE - Perù	1
PK - Pakistan	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.244

Nome	#
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease	378
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol	371
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.	272
Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency	259
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease.	248
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients	247
Severe HDL deficiency due to novel defects in the ABCA1 transporter	242
Functional lecithin: Cholesterol acyltransferase Is not required for efficient atheroprotection in humans	230
Totale	2.247

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	101	0	0	0	0	0	7	19	29	5	25	11	5
2021/2022	191	4	37	36	8	6	3	12	11	17	6	35	16
2022/2023	171	18	22	8	9	30	27	1	15	22	1	4	14
2023/2024	89	4	6	8	12	17	6	13	5	3	0	2	13
2024/2025	345	6	1	10	23	65	63	23	27	26	11	40	50
2025/2026	658	72	30	57	142	317	40	0	0	0	0	0	0
Totale													2.247